Loading…
This event has ended. Visit the official site or create your own event on Sched.
Welcome to the Science Summit at the United Nations General Assembly (UNGA77)

Please Register by clicking HERE

Registration is free of charge. You can register yourself and also other colleagues (up to 10 people).

After you have registered, you will receive two emails: one from Eventbrite with your ticket, and 15 min later, one from SCHED inviting you to create your username and password (these will be your  SCHED login details to access the conference each time).

Once you have your SCHED login details, you can select the session(s) you would like to attend and be able to see the ZOOM link to join your selected sessions.

All times in the AGENDA are New York Local (Eastern Daylight Time (EDT)). To view times in another time zone, please use the "Timezone" box located below on the right.
Back To Schedule
Thursday, September 29 • 9:00am - 12:00pm
(REF 29260 - IN-PERSON - Hybrid) Cervical cancer as a revealing example of worldwide disparities in cancer prevention and care - Convened by Institut Curie, Paris, France

Log in to save this to your schedule, view media, leave feedback and see who's attending!

Feedback form is now closed.

8th Scientific Summit of the 77th General Assembly of the United Nations 77 (SSUNGA77)
Latin America Group of the SSUNGA77 Sept. 13 to Sept. 30, 2022 New York, USA

Venue
Permanent Mission of France to the United Nations
245 East, 47th Street - 44th floor
New York, NY, 10017
USA
 
Cervical cancer as a revealing example of worldwide disparities in cancer prevention and care
 
Sept. 29, 2022
Organizers:
Prof. Christophe Le Tourneau, Head of the Department of Drug Development and Innovation, Institut Curie, Paris, France
Prof. Fabrice Lecuru, Head of Gynaecological Surgery, Department of Surgery, Institut Curie, Paris, France
Dr. Maud Kamal, Head of the Scientific Coordination Unit, Department of Drug Development and Innovation, Institut Curie, Paris, France
Participants:
Dr. Carolina Wiesner, Director, Instituto Nacional de Cancerología de Colombia, Bogota, Colombia
Dr. Partha Basu, Deputy Head, Early Detection, Prevention & Infections Branch, WHO, International Agency for Research & Cancer, Lyon, France
Prof. Hussein Kidanto, Associate Dean, Aga Khan University, Dar es Salaam, Tanzania
Prof. Aljosa Mandic, Head of Gynaecology Oncology Department and President of Serbian Society of Gynaecology Oncology, Oncology Institute of Vojvodina, Novi Sad, Serbia
 

 
Cancer is one of the most important public health problem with an increasing incidence. Huge disparities in prevention and care exist across regions of the world. Acting on these disparities would significantly decrease cancer incidence and mortality. Cervical cancer is a compelling example, since prevention and high quality care dramatically reduce its incidence and mortality.
Cervical cancer is the second most common cause of cancer death in women worldwide. Half a million of women per year are diagnosed with cervical cancer worldwide, and 270,000 women die from cervical cancer every year. In countries with adequate screening practices, the incidence and mortality rates of cervical cancer have been stable over the last years with a low mortality to incidence ratio. The mortality remains however high in populations with inadequate or absent screening practices. Incidence and mortality levels due to cervical cancer vary according to geographical regions. In the extended European Union, mortality rates are much higher in Central and Eastern countries. Rates also largely differ between Northern America and South America.
More recently, vaccination approaches against the Human Papilloma Virus (HPV) have been shown effective in reducing the incidence of cervical cancer that is most of time induced by the HPV. Large differences also exist across the globe in terms of access, political incentives and populations’ willingness to vaccination against HPV.
Finally, novel immunotherapeutics have been developed to fight advanced cervical cancer, with an access in a very limited number of countries. Overall, cervical cancer is one of the most revealing example of worldwide disparities in cancer prevention and care, with one or the other being true for other cancers.
During our session, we will provide an overview on global and local prevention strategies related to cervical cancer worldwide and discuss new therapeutic approaches and advances in translational research in this field. Speakers with epidemiological, medical, and social backgrounds from France, Colombia, WHO, Tanzania, and Serbia will participate in this session.

Speakers
avatar for Partha Basu

Partha Basu

Deputy Head Early Detection, Prevention & Infections Branch, WHO, IARC, Lyon France
Dr. Partha Basu is presently the Acting Head of Cancer Early Detection, Prevention & Infection Branch at International Agency for Research on Cancer, which is the specialized cancer agency of the World Health Organization. Dr. Basu is an MD in gynecology and PhD in clinical oncology... Read More →
avatar for Maud Kamal

Maud Kamal

Scientific manager, Dept of Drug Development & Innovation, Institut Curie
Maud Kamal, PhD is the scientific manager of the department of Drug Development and Innovation (D3i) at Institut Curie. She heads the scientific coordination unit of the department in charge of precision medicine projects and Institut Curie Molecular Tumour Board. Following a BSc... Read More →
avatar for Hussein Kidanto

Hussein Kidanto

Associate Dean, Aga Khan University, Dar es Salaam, Tanzania
Hussein Lesio Kidanto is a Tanzanian medical doctor. He graduated from School of Medicine, University of Marmara, Turkey (1992), and University of Dar es salaam (2000) and holds a PhD in Public Health from Umea University, Sweden (2009), on “Quality of perinatal care through clinical... Read More →
avatar for Fabrice Lecuru

Fabrice Lecuru

Head of Gynaecologic Oncologic Surgery, Institut Curie, Paris, France
Fabrice LECURU (MD,PhD) is the medical and scientific manager of surgical gynecologic oncology at Institut Curie. Following a residency in obstetrics and gynecology, he obtained a National Diploma in 1991. He did a fellowship (1991-1995), became a Praticien Hospitalo-Universitaire... Read More →
avatar for Aljoša Mandić

Aljoša Mandić

Head of Gynaecology Oncology Department, Institute of Vojvodina, Novi Sad, Serbia
Prof. Aljoša Mandić is a the Head of Gynecology at the Oncology Institute of Vojvodina, Serbia and full professor at the University of Novi Sad and the University of Istočno Sarajevi, Bosnia and Hercegovina. He is President of the Serbian Society of Gynecological Oncology. During... Read More →
avatar for Christophe Le Tourneau

Christophe Le Tourneau

Head of the Dept of Drug Development & innovation, Institut Curie, Paris, France
Christophe Le Tourneau is senior Medical Oncologist at the Institut Curie and Professor of Medicine at Paris-Saclay University. He is heading the Department of Drug Development and Innovation (D3i), as well as the Head and Neck Clinic. Christophe is leading the early phase clinical... Read More →
avatar for Carolina Wiesner

Carolina Wiesner

Director, Instituto Nacional de Cancerología de Colombia, Bogota, Colombia

Conveners
avatar for Maud Kamal

Maud Kamal

Scientific manager, Dept of Drug Development & Innovation, Institut Curie
Maud Kamal, PhD is the scientific manager of the department of Drug Development and Innovation (D3i) at Institut Curie. She heads the scientific coordination unit of the department in charge of precision medicine projects and Institut Curie Molecular Tumour Board. Following a BSc... Read More →
avatar for Fabrice Lecuru

Fabrice Lecuru

Head of Gynaecologic Oncologic Surgery, Institut Curie, Paris, France
Fabrice LECURU (MD,PhD) is the medical and scientific manager of surgical gynecologic oncology at Institut Curie. Following a residency in obstetrics and gynecology, he obtained a National Diploma in 1991. He did a fellowship (1991-1995), became a Praticien Hospitalo-Universitaire... Read More →
avatar for Christophe Le Tourneau

Christophe Le Tourneau

Head of the Dept of Drug Development & innovation, Institut Curie, Paris, France
Christophe Le Tourneau is senior Medical Oncologist at the Institut Curie and Professor of Medicine at Paris-Saclay University. He is heading the Department of Drug Development and Innovation (D3i), as well as the Head and Neck Clinic. Christophe is leading the early phase clinical... Read More →



Thursday September 29, 2022 9:00am - 12:00pm EDT
Permanent Mission of France to the United Nations 245 East, 47th Street - 44th floor New York, NY, 10017 USA